Iatrogenicity : (Record no. 92577)

MARC details
000 -LEADER
fixed length control field 06283cam a2200637Ii 4500
001 - CONTROL NUMBER
control field on1029759751
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221128213138.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu|||unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180329s2018 nju ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780813586434
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0813586437
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780813586410
035 ## - SYSTEM CONTROL NUMBER
System control number 1455653
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1029759751
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED078000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED010000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Iatrogenicity :
Subtitle Causes and Consequences of Iatrogenesis in Cardiovascular Medicine
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New Brunswick, New Jersey :
Name of producer, publisher, distributor, manufacturer Rutgers University Press Medicine,
Date of production, publication, distribution, manufacture, or copyright notice 2018.
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 ## - ABSTRACT
Abstract "Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. . "--
Assigning source Provided by publisher.
505 0# - CONTENTS
Contents Intro; Title Page; Copyright; Contents; Contributors; The Concept of Iatrogenicity; Part I: Medical Harm; Chapter 1. Iatrogenicity: Definition, History, and Modern Context; Chapter 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions; Chapter 3. Risk Management: The Medical Center Administration Perspective; Chapter 4. Iatrogenicity from the Patient's Perspective; Chapter 5. A Naturopathic Perspective on Iatrogenesis; Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
505 8# - CONTENTS
Contents Chapter 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and SyndromesChapter 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Chapter 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension; Chapter 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes; Chapter 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
505 8# - CONTENTS
Contents Chapter 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on PreeclampsiaChapter 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect; Chapter 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents; Chapter 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System; Chapter 16. Iatrogenicity and Antianginal Drugs; Chapter 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?; Chapter 18. Cardiovascular Iatrogenicity in Older Adults
505 8# - CONTENTS
Contents Part III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and SurgeriesChapter 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology; Chapter 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology; Chapter 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries; Chapter 22. Iatrogenic Aspects of Cardiac Electrophysiology; Chapter 23. Iatrogenic Aspects in Cardiac Device Therapy
505 8# - CONTENTS
Contents Chapter 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic ModalitiesPart IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications; Chapter 25. Trained Athletes; Chapter 26. Sports Cardiology; Chapter 27. Dangers of Lifestyle Modification Advice; Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine; Chapter 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications; Chapter 29. Interactions Between Supplements and Medications; Index
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 072
650 #0 - SUBJECT HEADINGS
Subject term Cardiovascular system
General subdivision Diseases
-- Treatment.
650 #0 - SUBJECT HEADINGS
Subject term Iatrogenic diseases.
700 1# - ADDED PERSONAL NAME
Added personal author Gussak, Ihor,
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Kostis, John B.,
Relator term editor.
856 40 - ONLINE RESOURCE
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1455653">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1455653</a>
Link text Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (EBSCO, viewed March 29, 2018).
938 ## -
-- EBL - Ebook Library
-- EBLB
-- EBL4789855
938 ## -
-- YBP Library Services
-- YANK
-- 15247127
938 ## -
-- YBP Library Services
-- YANK
-- 15245802
938 ## -
-- EBSCOhost
-- EBSC
-- 1455653
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library Stenhouse Library   28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1455653 28/11/2022 Electronic book
London Health Libraries Koha Consortium privacy notice